Pereira DOL, Palay DMS

Language: Spanish
References: 20
Page: 215-222
PDF size: 111.52 Kb.

ABSTRACT

A therapeutic intervention was carried out in 12 patients with exogenous obesity, assisted in the Endocrinology Department from "Saturnino Lora Torres" Teaching Clinical Surgical Provincial Hospital in Santiago de Cuba, from July, 2013 to the same month of 2014, who were randomly selected and then assigned into 2 groups of identical quantity of members: a control group which had the diet as the only therapy, and that of study which received diet and metformine as treatment; in order to determine the effectiveness of this drug in the weight loss. The information was analyzed and processed through the hypothesis tests of Mann Whitney and of means comparison, with an error of 5%, and it was obtained that this drug was more effective combined with the diet that the dietary monotherapy as the only treatment.

REFERENCES

1. American Association of Clinical Endocrinologist/American College of Endocrinology Obesity Task Force. Position statement on the prevention, diagnosis, and treatment of obesity. Endocr Pract. 1998;4:297-330.

2. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA. 2003;289:187-93.

3. Van Hubbard S. Defining overweigth and obesity: what are the issues? Am J Clin Nutr. 2000;72:1067-8.

4. Kuczmarski RJ, Flegal KM. Criteria for definition of overweight in transition: background and recommendations for the Unites States. Am J Clin Nutr. 2008;72:1074-81.

5. Fernández-Real JM, Vayreda M, Casamitjana R, Saez M, Ricart W. Índice de masa corporal (IMC) y porcentaje de masa grasa. Med Clin (Barc). 2001;117:681-4.

6. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 2009;73:460-8.

7. Mokdad AH, Ford ES, Browman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76-9.

8. Rodríguez Artalejo F, López García E, Gutiérrez Fisac JL, Banegas Banegas JR, Lafuente Urdinguio PJ, Domínguez Rojas V. Changes in the prevalence of overweight and obesity and their risk factors in Spain, 1987-1997. Prev Med. 2002;34:72-81.

9. Schwartz MW, Morton GJ. Obesity: keeping hunger at bay. Nature. 2002;418:595- 7.

10. Cummings DE, Schwartz MW. Genetics and pathophysiology of human obesity. Annu Rev Med. 2003;54:453-71.

11. Pi Sunyer X. A clinical view of the obesity problem. Science. 2003;299:859-60.

12. Barsh GS, Farooqi IS, O’Rahilly S. Genetics of body-weight regulation. Nature. 2009;404:644-51.

13. Rankinen T, Perusse L, Weisnagel SJ, Snyder EE, Chagnon YC, Bouchard C. The human obesity gene map: the 2001 update. Obes Res. 2002;10:196-243.

14. Domínguez Reyes CA. Adiponectina: el tejido adiposo más allá de la reserva inerte de energía. Rev Endocrinol Nutr. 2007;15(3):149-55.

15. Jacobson P, Ukkola O, Rankinen T, Snyder EE, Leon AS, Rao DC, et al. Melanocortin 4 receptor sequence variations are seldom a cause of human obesity: the Swedish Obese Subjects, the HERITAGE Family Study, and a Memphis cohort. J Clin Endocrinol Metab. 2002;87: 4442-6.

16. Plagemann A, Harder T, Franke K, Kohlhoff R. Long-term impact of neonatal breast-feeding on body weight and glucose tolerance in children of diabetic mothers. Diabetes Care. 2007;25:16-22.

17. National Task Force on the Prevention and Treatment of Obesity. Overweight, obesity, and health risk. Arch Intern Med. 2008;160:898-904.

18. Mather KJ, Verna S, Anderson TJ. Improved endothelial function with metformin in type 2 diabetes mellitus. J Am Coll Cardiol. 2007;37:1344-1350.

19. Misbin RI, Green l, Stadel BV. Lactic acidosis in patients with diabetes treated with etformin. N Engl J Med. 2008;338:265.

20. Bailey CJ, Turner RC. Metformin. N Engl J Med. 2006; 334: 574-9.